Amgen acquires Onyx Pharmaceuticals for $125 per share in cash.

Vical's restructuring will leave the company with approximately 74 employees.

Top four graduate students to be hosted at GE Healthcare Life Science's Uppsala site.

Andrew Derodra will join Skyepharma in the fourth quarter of 2013.

Takeda Peru will be headquartered in Lima and will be responsible for sales and marketing of Takeda's products in Peru.

Parameter Stability Storage adds validated space in anticipation of pending contracts.

The MHRA has issued a warning to the public not to use unlicensed traditional Chinese medicines after discovering that some of them contain dangerously high levels of lead, mercury and arsenic.

Experts, including researchers at I Holland, Natoli, and Rutgers University’s Engineering Research Center for Structured Organic Particulate Systems, are seeking a greater understanding of the fundamental causes of tablet sticking and are developing predictive models to more quickly find solutions to specific sticking problems.

RABS is a flexible barrier system that maximizes product control but minimizes operator interaction when best practices are followed.

Agencies collaborate to ensure consistent product quality.

INTERPHEX and the Parenteral Drug Association (PDA) announced a three-year sponsorship agreement, which aligns the objectives of both organizations to service key needs of the global pharmaceutical and biopharmaceutical industry.

FDA has granted Novartis breakthrough therapy designation to BYM338 for sporadic inclusion body myositis.

The acquisition expands SeraCare's portfolio of products designed to help diagnostic researchers develop in vitro diagnostic assays.

ABPI toolkit provides guidance to pharmaceutical companies on how to meet clinical trial transparency requirements

The closure will impact 240 employees through a multistage process starting in December 2013.

The fund's first investment will be in SetPoint Medical, a California company.

ViiV Healthcare, a specialist HIV pharmaceutical company of GSK, Pfizer, and Shionogi gains approval for new HIV-1 treatment.

Alpha Packaging's new line will consist of more than a dozen injection blow molded and extrusion blow molded bottles.

CDER withdraws some outdated guidance documents and makes plans to finalize others.

Pharmstandard OJSC seeks to bolster its over-the-counter business through acquiring Bever Pharmaceutical.

Understanding the supply-chain challenge and coupling high-efficiency chromatographic techniques with information-rich detectors are leading to improvements in the management of extractables and leachables in parenteral drugs.

Amgen, Servier collaborate ivabraline and other cardiovascular products.

EMD Millipore and PharmaCell have entered into a collaboration to develop optimized large-scale expansion and harvest of HepaRG cells using bioreactor technology.

Marken's expansion is fully operational to support clinical-trial material supply.

A simple, rapid analytical method for the determination of palladium in pharmaceutical production samples will speed up development and optimization of reactions involving palladium catalysts.

Synthesis of tetracycline derivatives with novel substituents has been challenging. Using an approach based on a Michael-Dieckmann reaction, new compounds with enhanced antibiotic properties are now being prepared on a large scale.

Jubilant HollisterStier added an ampul filling line utilizing a rigid barrier system.

Till, a PhRMA vice president, will lead AAPS starting in November; Executive Council and Section leadership positions were also announced.